ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NMRA Neumora Therapeutics Inc

9.99
0.04 (0.40%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)
Total Revenue 000
Operating Income -56.86M-114M-60.07M
Pre Tax Income -53.03M-108.46M-53.72M
Net Income -53.03M-108.73M-53.72M
Preferred Dividends 000
Basic Earnings Per Share (EPS) 000
EBIT -56.87M-114.11M-60.09M
EBITDA -56.69M-113.84M-59.92M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 000
Operating Income -237.32M-135.87M-252.1M
Pre Tax Income -237.31M-130.9M-235.66M
Net Income -237.31M-130.9M-235.93M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -0.239-0.256-0.575
EBIT -237.31M-135.47M-252.27M
EBITDA -236.79M-135.28M-251.43M

Your Recent History

Delayed Upgrade Clock